封面
市場調查報告書
商品編碼
2058392

非侵入式生物感測器市場:按技術、產品類型、最終用戶和地區分類

Non-Invasive Biosensor Market, By Technology, By Product Type, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 254 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,非侵入式生物感測器市場規模將達75億美元,到2033年將達到167億美元。預計從2026年到2033年,該市場將以12.5%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 75億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 12.50% 2033年市場規模預測: 167億美元

非侵入式生物感測器是一種新型診斷設備,無需任何侵入性操作即可檢測物質或疾病。此技術利用汗液、淚液或唾液進行診斷。目前,市面上已有使用非侵入式生物感測器進行血糖值監測和血液成分監測的產品。此外,許多非侵入式生物感測器正在研發或進行臨床試驗,用於癌症和血液酒精濃度檢測等新應用。

市場動態

預計未來一段時間內,新型非侵入式生物感測器的核准和上市將推動全球非侵入式生物感測器市場的成長。例如,2016年,Nemaura Medical公司憑藉其最新產品-微創無線連續血糖監測儀「sugarBEAT」獲得了歐盟CE核准。此外,2013年,Integrity Applications公司也為其新型非侵入式血糖監測儀「GlucoTrack DF-F」獲得了CE認證。針對新型非侵入式生物感測器的研發活動活性化,預計也將推動市場在不久的將來成長。例如,2017年,麥克萊恩醫院宣布其用於檢測血液酒精濃度的非侵入式皮膚貼片「LabPatch-alcohol」已進入臨床試驗階段。 「LabPatch-alcohol」目前處於I期臨床試驗的早期階段。此外,糖尿病盛行率的不斷上升預計也將導致對診斷非侵入式生物感測器的需求增加。根據世界衛生組織 (WHO) 2014 年的報告,全球約有 8.5% 的 18 歲及以上成年人(即 4.22 億人)患有糖尿病。

本次調查的主要特點

  • 本研究確定了各個細分市場的潛在商機,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球非侵入式生物感測器市場的主要參與者進行了分析:公司概況、財務表現、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
  • 透過利用本報告中的見解,企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球非侵入式生物感測器市場報告面向產業內的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以利用分析非侵入式生物感測器市場中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 近期產品核可上市
  • 管道分析
  • 監管趨勢
  • 救贖方案
  • PEST分析
  • 波特的分析
  • 流行病學

第4章 全球非侵入式生物感測器市場:依技術分類,2021-2033年

  • 光學的
  • 經皮型
  • 熱的
  • 其他

第5章 全球非侵入式生物感測器市場:依產品類型分類,2021-2033年

  • 血糖值監測儀
  • 血液分析監測儀
  • 呼吸酒精檢測儀
  • 其他

第6章 全球非侵入式生物感測器市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷檢查室
  • 居家醫療
  • 其他

第7章 全球非侵入式生物感測器市場:按地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太地區其他國家和日本
    • 澳洲
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 中非
    • 南非
    • 北非

第8章 競爭情勢

  • 熱圖分析
  • 公司簡介
    • Nemaura Medical, Inc.
    • MediWise Ltd.
    • Integrity Applications Inc.
    • OrSense
    • Medtronic Plc
    • GE Healthcare
    • Philips Healthcare
    • Akers Biosciences, Inc.
    • Abbott Laboratories

第9章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1704

Non-Invasive Biosensor Market is estimated to be valued at USD 7.5 Bn in 2026 and is expected to reach USD 16.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 7.5 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 12.50% 2033 Value Projection: USD 16.7 Bn

Non-invasive biosensors are novel diagnosis devices, which do not require any invasive procedure for detection of any substance or disease. This technology uses sweat, tears, or saliva for diagnostic purpose. Glucose monitoring and blood analytes monitor have become available in the market, which uses non-invasive biosensors. Moreover, there are many non-invasive biosensors under development and under clinical trial for new applications such as cancer and blood alcohol concentration detection.

Market Dynamics

Increasing approval and launches of novel non-invasive biosensors is expected to boost growth of global non-invasive biosensors market in the near future. For instance, in 2016, Nemaura Medical, Inc. received CE approval in the European Union for its latest sugarBEAT, a minimally invasive wireless continuous glucose monitor. Moreover, in 2013, Integrity Applications Inc. received CE marking for its new GlucoTrack DF-F device, a non-invasive blood glucose monitoring device. Increasing research and development activities for developing novel non-invasive biosensors is also expected to drive growth of market in the near future. For instance, in 2017, Mclean Hospital announced that LabPatch-alcohol, its non-invasive skin patch that detects blood alcohol concentration, is in clinical trial. LabPatch-alcohol is in early Phase 1 stage of clinical trial. Furthermore, increasing prevalence of diabetes is also expected to increase demand for non-invasive biosensors for diagnosis. According to the World Health Organization (WHO), 2014, around 8.5% of adults aged 18 and above accounting for 422 million adults were suffering from diabetes worldwide.

Key features of the study

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global non-invasive biosensors market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Nemaura Medical, Inc., MediWise Ltd., Integrity Applications Inc., OrSense, Medtronic Plc, GE Healthcare, Philips Healthcare, Akers Biosciences, Inc. and Abbott Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global non-invasive biosensors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the non-invasive biosensors market

Market Segmentation

  • By Technology (Revenue, USD Bn, 2021-2033)
    • Optical
    • Transdermal
    • Thermal
    • Others
  • By Product Type (Revenue, USD Bn, 2021-2033)
    • Glucose monitors
    • Blood Analytes Monitors
    • Breathalyzers
    • Others
  • By End User (Revenue, USD Bn, 2021-2033)
    • Homecare Settings
    • Hospitals
    • Diagnostic Lab
    • Others
  • By Region (Revenue, USD Bn, 2021-2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
    • Nemaura Medical, Inc.
    • MediWise Ltd.
    • Integrity Applications Inc.,
    • OrSense
    • Medtronic Plc
    • GE Healthcare
    • Philips Healthcare
    • Akers Biosciences, Inc.
    • Abbott Laboratories.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Product Type
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Recent Product Approval/Launch
  • Pipeline Analysis
  • Regulatory Scenario
  • Reimbursement Scenario
  • PEST Analysis
  • PORTER Analysis
  • Epidemiology

4. Global Non-Invasive Biosensors Market, By Technology, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Optical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Thermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

5. Global Non-Invasive Biosensors Market, By Product Type, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Glucose monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Blood Analytes Monitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Breathalyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

6. Global Non-Invasive Biosensors Market, By End User, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Diagnostic Lab
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Homecare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)

7. Global Non-Invasive Biosensors Market, By Region, 2021-2033 (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2033
  • North America
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of APAC Japan
      • Australia
  • Middle East
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Technology, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Product Type, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By End User, 2021-2033 (US$ Bn)
    • Market Size and Forecast, By Country, 2021-2033 (US$ Bn)
      • Central Africa
      • South Africa
      • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Nemaura Medical, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • MediWise Ltd.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Integrity Applications Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • OrSense
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medtronic Plc
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GE Healthcare
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Philips Healthcare
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Akers Biosciences, Inc.
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Abbott Laboratories
      • Company Overview
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact